Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT02690766
Eligibility Criteria:
Inclusion Criteria:
* African American women, ages 30
* No evidence of pregnancy, as evidenced by negative urine pregnancy test.
* Diagnosed with type 2 diabetes by their provider
* Diagnosed with Stage I-III breast or endometrial cancer
* Completed treatment for breast or endometrial cancer at least 4 months and no more 5 years ago English-speaking
* Agree to participate in all aspects of the semi-structured interview (Aim 1)
* Agree to participate in all aspects of the feasibility study, including group sessions (Aim 2)
* Access to the internet via phone or computer
* Access to a working phone for personal use
Exclusion Criteria:
* Non-English speaking
* Recent epilepsy, cardiac event or stroke in last 6 months,special nutritional needs (e.g. current evidence of malignancy; HIV)
* History of epilepsy, cardiac event or stroke within the last year
* Known diagnosis of HIV
* Known new malignancy
* Less than 4 months or more than 2 years post treatment of Stage I-III breast or endometrial cancer.
* No diagnosis of type 2 diabetes
* No self-report of African American race/ethnicity
* No access to a phone for personal use
* No access to the internet via computer or mobile phone
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
30 Years
Maximum Age:
99 Years
Study:
NCT02690766
Study Brief:
Protocol Section:
NCT02690766